| Name | Visionworks |
|---|---|
| Organization Name | Visionworks Inc |
| Location | 1850 Adams St, Ste 112, Mankato, Minnesota 56001 |
| Type | Eyewear Supplier (Equipment, not the service) |
| Phone | (507) 387-6358 |
| Participate in Medicare | Medicare enrolled and may accept medicare assignment. Please check with the supplier if they accept medicare-approved amount before you get your prescription drugs, equipment or supplies from this supplier. |
News Archive
Being overweight is a health concern, and using only body mass index (BMI) to determine weight classification may not give an accurate picture of a person's health, according to an advisory published in Circulation: Journal of the American Heart Association.
AEterna Zentaris Inc. (the "Company"), a global biopharmaceutical company focused on endocrine therapy and oncology, today reported Phase 3 results for its European efficacy trial Z-036 in benign prostatic hyperplasia (BPH), with cetrorelix pamoate.
Cancer researchers are a step closer to finding a cure for advanced prostate cancer after effectively combining an anti-cancer drug with a viral gene therapy in vivo using novel ultrasound-targeted microbubble-destruction (UTMD) technology.
Archimedes Inc., a healthcare modeling company, announced today that it has entered into a Research Collaboration Agreement with the U.S. Food and Drug Administration (FDA) to develop a computer model of clinical trials evaluating weight loss medications. The model will be used to obtain a better understanding of the benefits of weight loss against the long-term risks of cardiovascular outcomes in patients treated with weight loss drugs.
The two-paper Series is led by authors from the Berlin Institute of Technology and the Geneva Graduate Institute, and accompanied by a Comment from Germany's Minister of Health, Hermann Gröhe.
› Verified 8 days ago
| NPI Number | 1083790182 |
| Organization Name | VISION WORLD INC |
| Doing Business As | VISION WORLD |
| Type | Eyewear Supplier (Equipment, not the service) |
| Address | 1850 Adams, Suite 112, Mankato, MN 56001 |
| Phone Number | 507-387-6358 |
News Archive
Being overweight is a health concern, and using only body mass index (BMI) to determine weight classification may not give an accurate picture of a person's health, according to an advisory published in Circulation: Journal of the American Heart Association.
AEterna Zentaris Inc. (the "Company"), a global biopharmaceutical company focused on endocrine therapy and oncology, today reported Phase 3 results for its European efficacy trial Z-036 in benign prostatic hyperplasia (BPH), with cetrorelix pamoate.
Cancer researchers are a step closer to finding a cure for advanced prostate cancer after effectively combining an anti-cancer drug with a viral gene therapy in vivo using novel ultrasound-targeted microbubble-destruction (UTMD) technology.
Archimedes Inc., a healthcare modeling company, announced today that it has entered into a Research Collaboration Agreement with the U.S. Food and Drug Administration (FDA) to develop a computer model of clinical trials evaluating weight loss medications. The model will be used to obtain a better understanding of the benefits of weight loss against the long-term risks of cardiovascular outcomes in patients treated with weight loss drugs.
The two-paper Series is led by authors from the Berlin Institute of Technology and the Geneva Graduate Institute, and accompanied by a Comment from Germany's Minister of Health, Hermann Gröhe.
› Verified 8 days ago
| NPI Number | 1942577275 |
| Organization Name | VISIONWORKS, INC. |
| Doing Business As | VISIONWORKS |
| Type | Eyewear Supplier (Equipment, not the service) |
| Address | 1850 Adams St, Suite #112, Mankato, MN 56001 |
| Phone Number | 507-387-6358 |
News Archive
Being overweight is a health concern, and using only body mass index (BMI) to determine weight classification may not give an accurate picture of a person's health, according to an advisory published in Circulation: Journal of the American Heart Association.
AEterna Zentaris Inc. (the "Company"), a global biopharmaceutical company focused on endocrine therapy and oncology, today reported Phase 3 results for its European efficacy trial Z-036 in benign prostatic hyperplasia (BPH), with cetrorelix pamoate.
Cancer researchers are a step closer to finding a cure for advanced prostate cancer after effectively combining an anti-cancer drug with a viral gene therapy in vivo using novel ultrasound-targeted microbubble-destruction (UTMD) technology.
Archimedes Inc., a healthcare modeling company, announced today that it has entered into a Research Collaboration Agreement with the U.S. Food and Drug Administration (FDA) to develop a computer model of clinical trials evaluating weight loss medications. The model will be used to obtain a better understanding of the benefits of weight loss against the long-term risks of cardiovascular outcomes in patients treated with weight loss drugs.
The two-paper Series is led by authors from the Berlin Institute of Technology and the Geneva Graduate Institute, and accompanied by a Comment from Germany's Minister of Health, Hermann Gröhe.
› Verified 8 days ago
News Archive
Being overweight is a health concern, and using only body mass index (BMI) to determine weight classification may not give an accurate picture of a person's health, according to an advisory published in Circulation: Journal of the American Heart Association.
AEterna Zentaris Inc. (the "Company"), a global biopharmaceutical company focused on endocrine therapy and oncology, today reported Phase 3 results for its European efficacy trial Z-036 in benign prostatic hyperplasia (BPH), with cetrorelix pamoate.
Cancer researchers are a step closer to finding a cure for advanced prostate cancer after effectively combining an anti-cancer drug with a viral gene therapy in vivo using novel ultrasound-targeted microbubble-destruction (UTMD) technology.
Archimedes Inc., a healthcare modeling company, announced today that it has entered into a Research Collaboration Agreement with the U.S. Food and Drug Administration (FDA) to develop a computer model of clinical trials evaluating weight loss medications. The model will be used to obtain a better understanding of the benefits of weight loss against the long-term risks of cardiovascular outcomes in patients treated with weight loss drugs.
The two-paper Series is led by authors from the Berlin Institute of Technology and the Geneva Graduate Institute, and accompanied by a Comment from Germany's Minister of Health, Hermann Gröhe.
› Verified 8 days ago
The Ecumen Store Type: Durable Medical Equipment & Medical Supplies Supplier Location: 718 Mound Ave, Mankato, Minnesota 56001 Phone: (844) 385-8582 | |
Cvs Pharmacy #06635 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 1610 Monks Ave, Mankato, Minnesota 56001 Phone: (507) 625-1553 | |
Cvs Pharmacy 03054 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 1175 Madison Ave, Mankato, Minnesota 56001 Phone: (507) 625-1791 | |
Cvs Pharmacy #16190 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 1850 Adams St, Mankato, Minnesota 56001 Phone: (507) 625-9009 | |
Walmart Pharmacy 10-1473 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 1881 Madison Ave, Mankato, Minnesota 56001 Phone: (507) 625-1660 |